Position in KOD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,828,158
+$619,056 QoQ
Shares Held
47,958
+10.9% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in KOD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. KOD ranks #94 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in KOD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,828,158 | 47,958 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,209,102 | 43,244 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $793,273 | 48,459 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $182,523 | 48,934 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $146,889 | 52,274 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $512,116 | 51,469 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $131,118 | 50,237 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $132,800 | 56,511 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $294,165 | 55,925 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $167,409 | 55,069 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $98,559 | 54,755 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $390,360 | 56,574 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $339,040 | 54,684 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $383,460 | 53,556 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $412,433 | 53,286 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $393,032 | 51,444 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $276,885 | 35,866 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,007,146 | 35,470 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,445,682 | 35,900 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,256,674 | 35,018 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,208,469 | 37,115 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $5,848,487 | 39,810 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,151,395 | 36,335 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,366,072 | 43,719 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,729,840 | 36,265 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||